Breast cancer; Fluorescence; Nonintrusive inspection; Optical images; Resistance(biology); Antibodies; Biodeterioration; Biological detection; Cells(biology); Clinical medicine; In vitro analysis; In vivo analysis; Metastasis; Molecular dynamics; Near infrared radiation; Proteins(conjugated); Receptor sites(physiology); Response(biology); Therapy; Emissive polymersomes; Near infrared florescence; Therapeutic resistance; Molecular profiling; Personalized medicine; Imaging; Active targeting; Fnb(fluoronitrobenzoic acid);
机译:LSD1(KDM1A / AOF2)对ERα-PELP1-HER2信号的整合提供了组合治疗机会,可规避乳腺癌中的激素抵抗
机译:LSD1(KDM1A / AOF2)对ERα-PELP1-HER2信号的整合提供了组合治疗机会,可规避乳腺癌中的激素抵抗
机译:通过避开GST介导的耐药性,对阿霉素和致敏乳腺癌细胞进行纳米粒子定向的亚细胞定位
机译:新型靶向乳腺癌的细胞穿透肽偶联基因载体与治疗性microRNA的乳腺癌特异性递送。
机译:乳腺癌的过继T细胞疗法:肿瘤微环境中T细胞浸润的定义和规避障碍。
机译:LSD1(KDM1A / AOF2)对ERα-PELP1-HER2信号的整合提供了组合治疗机会可规避乳腺癌中的激素抵抗
机译:Annamycin避免由多药抗性相关蛋白(MRP)介导的乳腺MCF-7和小细胞肺UMCC-1癌细胞系介导的抵抗力,所述小细胞肺UMCC-1癌细胞系为耐依托泊苷
机译:通过非侵入性光学成像规避治疗抗性和传播乳腺癌细胞的出现。